Blastic Indeterminate Dendritic Cell Tumor Associated With Chronic Myelomonocytic Leukemia

Am J Dermatopathol. 2022 Sep 1;44(9):691-695. doi: 10.1097/DAD.0000000000002202. Epub 2022 Apr 11.

Abstract

Indeterminate dendritic cell tumor (IDCT) is an exceedingly rare neoplasm that can be associated with hematopoietic malignancies. We report a case of multifocal cutaneous blastic indeterminate dendritic cell tumor (BIDCT) in a 75-year-old man with chronic myelomonocytic leukemia showing blastic histiocytoid morphology, positivity for CD1a and S100, and no expression of langerin. We present a literature review on the 11 reported cases of IDCTs/BIDCTs associated with chronic myelomonocytic leukemia (CMML), including this case. The clinicopathological characteristics have been summarized. The IDCT and CMML cells are clonally related in 4 tested cases. Patients with IDCT/BIDCT associated with CMML seem to have worse clinical outcomes compared with patients with IDCT not associated with CMML.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Dendritic Cell Sarcoma, Interdigitating* / pathology
  • Dendritic Cells / pathology
  • Humans
  • Leukemia, Myelomonocytic, Chronic* / complications
  • Leukemia, Myelomonocytic, Chronic* / pathology
  • Male
  • Skin Neoplasms* / pathology